Review
Open access
Sep 2026
T-Cell Redirecting Antibodies for the Treatment of Multiple Myeloma: Off-the-Shelf T-Cell Immunity
Dual-targeting strategies (combination of BsAbs targeting different tumor antigens or trispecific antibodies) are being intensively investigated to enhance the depth and duration of response.
N. V. van de Donk, F. Smits, C. O'Neill et al.
· Cancer Journal · 0 citations